Reimagining Obesity and Diabetes Care in the Era of GLP-1s

January 29–30, 2025

We’ve reached a pivotal moment in healthcare. While the obesity and diabetes epidemics rage on, GLP-1s and lifestyle programs are poised to redefine the status quo.

Industry leaders and physicians are eager to embrace these new innovations, but also concerned that critically high Rx costs will threaten not just healthcare budgets, but also the bottom line. What if we changed the way we think about caring for and curing obesity and diabetes? Can “moonshots” thinking turn us around?

Moonshots 2025 will unite visionary leaders, researchers and advocates to reimagine obesity and diabetes care in the era of GLP-1s. Join us to explore the most pressing issues along with bold new ideas to carry us forward.

Keynote Speakers

Mark Hyman, MD

Co-Founder and Chief Medical Officer, Function Health and 15x NYT Bestselling Author

Peter Attia, MD

Founder of Early Medical, host of The Drive podcast, and author of Outlive

Featured Speakers

We’re bringing together industry leaders to discuss the biggest breakthroughs in metabolic health

Adam Wolfberg, MD, MPH

Virta Health

Chief Medical Officer

Alan Moses, MD

Joslin Diabetes Center and Novo Nordisk A/S

Former Chief Medical Officer

Chris Palmer, MD

Harvard Medical School

Assistant Professor of Psychiatry

Frank Dumont, MD

Virta Health

Medical Director

Georgia Ede, MD

Nutritional and Metabolic Psychiatrist

Holly Lofton, MD

NYU Langone Health

Obesity Specialist

Ken Su

Google LLC

Product Lead, Applied AI for Healthcare and RiskAI

Kim Henrichsen, RN

St. Louis University and Saint Mary’s Hospital, SSM Health

Interim President

Featured Sessions

Walking the GLP-1 Tightrope: Balancing expectations, outcomes and financial realities

Join this panel of industry leaders as they dive into the complex questions surrounding GLP-1s today. Are these medications the miracle drugs they’re made out to be–or the financial tipping point for employers and health plans? This session explores how employers and health plans can craft thoughtful strategies to address competing priorities: delivering clinical outcomes while managing costs, balancing medical necessity against vanity use, and leveraging GLP-1s to drive retention without breaking the bank.

The Overlooked Connection Between Menopause and Metabolic Health

Menopause is more than a hot flash, with hormonal shifts setting women up for long-term struggles with weight regulation and insulin sensitivity. Looking for a quick-fix, many are turning to GLP-1s to lose weight. With more than 1 million entering menopause in the US each year, it’s time to acknowledge the connection between menopause, obesity and type 2 diabetes, and offer women the support they need to thrive in this period of life. Join this session to learn how these conditions are related and what downstream impact is possible by helping women renew their metabolic health.

Feeding the Mind: Nutrition’s Role in Treating Cognitive Disease and Mental Illness

Research shows that nutrition can transform the treatment of depression, bipolar disorder and even diseases like Alzheimer’s. Join two of the preeminent leaders in the field of metabolic psychiatry to explore the connection behind nutrition and mental health. Learn how a food-first approach can heal the brain through metabolic optimization and create impact far and wide for your members.

AI in Action: AI’s Most (and Least) Valuable Roles in Digital Health Today

The focus on AI in healthcare has shifted from “Should we use AI?” to “How can we leverage AI to create real value for patients, providers, and organizations?” As AI’s capabilities rapidly evolve, it is critical to identify the highest-value use cases while understanding where human expertise remains essential. Join leading AI and digital health experts to explore how AI can improve member and clinician experience today, and where a human touch outperforms automation.